Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siemens Healthineers AGSEMHF 78 EV-to-EBIT is 13.11 as of Aug. 22, 2026, which is 30% below its 10-year median of 18.81. GuruFocus rates SEMHF with a GF Score™ of 78/100 and a GF Value™ of $58.36 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 473 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 68.08% on this metric.
Siemens Healthineers AG (OTCPK:SEMHF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Siemens Healthineers AG's Enterprise Value for the quarter that ended in Jun. 2026 was $42,508 Mil.
Siemens Healthineers AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,838 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siemens Healthineers AG EV-to-EBIT Related Terms
Siemens Healthineers AG EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Siemens Healthineers AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siemens Healthineers AG EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Siemens Healthineers AG's EV-to-EBIT falls into.
Siemens Healthineers AG's current Enterprise Value is $50,307 Mil.
Siemens Healthineers AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,838 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siemens Healthineers AG (SEMHF) has a EV-to-EBIT of 13.11 as of Aug. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Siemens Healthineers AG and its competitors. This is 30% below median its historical median of 18.81. Over the past decade, Siemens Healthineers AG's EV-to-EBIT has ranged from 11.09 to 30.58. According to the industry distribution chart, Siemens Healthineers AG ranks #151 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 31.9%.
Is Siemens Healthineers AG's EV-to-EBIT too high?
Siemens Healthineers AG's current EV-to-EBIT of 13.11 is 30% below median its 10-year median of 18.81. Over the past 10 years, this metric has ranged from a low of 11.09 to a high of 30.58. The Medical Devices & Instruments industry median EV-to-EBIT is 18.87. Siemens Healthineers AG's value of 13.11 is 30.5% below this industry median. Based on the distribution chart, Siemens Healthineers AG ranks #151 out of 473 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Siemens Healthineers AG has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #151 out of 473 companies for EV-to-EBIT. This puts Siemens Healthineers AG in the upper half of its industry. The industry median EV-to-EBIT is 18.87. Siemens Healthineers AG's value of 13.11 is 30.5% below this benchmark. Historically, Siemens Healthineers AG's own EV-to-EBIT has ranged from 11.09 to 30.58 over the past decade. While the company's 10-year median is 18.81 vs. the industry median of 18.87, Siemens Healthineers AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.87, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siemens Healthineers AG's current EV-to-EBIT of 13.11 is 30.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current EV-to-EBIT is 13.11, which is 30% below median its own 10-year median of 18.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (SEMHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $58.36, compared to a current price of $47.59 — trading 18.5% below its estimated fair value. The current EV-to-EBIT is 13.11, which is 30% below median its 10-year median of 18.81 and 30.5% below the Medical Devices & Instruments industry median of 18.87. Siemens Healthineers AG's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Siemens Healthineers AG (SEMHF), the current EV-to-EBIT is 13.11 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siemens Healthineers AG (SEMHF) Overvalued in 2026?
Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued.
The current stock price of $47.59 is trading 18.5% below its estimated GF Value™ of $58.36.
GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.
Key valuation signals for SEMHF:
EV-to-EBIT: 13.11 (30% below median its 10-year median of 18.81)
GF Value™: $58.36 vs. price of $47.59 (18.5% below fair value)
Industry Position: 30.5% below the Medical Devices & Instruments median (#151 of 473)
No single metric tells the full story. See the SEMHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
78GF Score
Get the complete analysis for SEMHF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SEMHF has been successfully added to your 
